DGM
Darwin Global Management Portfolio holdings
AUM
$2.38B
This Quarter Return
+91.94%
1 Year Return
+81.43%
3 Year Return
+6,053.69%
5 Year Return
–
10 Year Return
–
AUM
$366M
AUM Growth
+$366M
(+128%)
Cap. Flow
+$159M
Cap. Flow
% of AUM
43.41%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
1
Reduced
2
Closed
1
Top Buys
| 1 |
TG Therapeutics
TGTX
|
$157M |
| 2 |
AMAM
Ambrx Biopharma, Inc. Common Stock
AMAM
|
$33.2M |
Top Sells
| 1 |
Keros Therapeutics
KROS
|
$17M |
| 2 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$10.1M |
| 3 |
argenx
ARGX
|
$4.66M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
TG Therapeutics
TGTX
$4.65B
| $157M | 42.99% | +10,451,241 | New | +$157M |
|
|
2
argenx
ARGX
$43.6B
| $106M | 29.06% | 285,198 -12,503 | -4% | -$4.66M |
|
|
AMAM
3
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
| $101M | 27.58% | 11,304,573 +3,720,084 | +49% | +$33.2M |
|
|
4
Keros Therapeutics
KROS
$618M
| $1.34M | 0.37% | 31,386 -397,146 | -93% | -$17M |
|
|
RXDX
5
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| – | – | -91,379 | Closed | -$10.1M |
|